Hologic (HOLX) Tops Q4 EPS by 19c; Offers Guidance

Hologic (NASDAQ: HOLX) reported Q4 EPS of $0.82, $0.19 better than the analyst estimate of $0.63. Revenue for the quarter came in at $953.3 million versus the consensus estimate of $864.85 million.

GUIDANCE:

Hologic sees Q1 2023 EPS of $0.60-$0.70, versus the consensus of $0.83. Hologic sees Q1 2023 revenue of $940-990 million, versus the consensus of $968.8 million.

Hologic sees FY2023 EPS of $2.51-$2.81, versus the consensus of $5.82. Hologic sees FY2023 revenue of $3700-3900 million, versus the consensus of $4774 million.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
• Ideal Power (IPWR) Tops Q2 EPS by 2c